| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL6A5 TINAGL1 DMBT1 COL4A6 COL16A1 COL19A1 CILP COL27A1 EMILIN1 HMCN1 MUC6 | 1.42e-05 | 188 | 234 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.29e-05 | 32 | 234 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.26e-04 | 42 | 234 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.96e-04 | 46 | 234 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.45e-04 | 11 | 234 | 3 | GO:0098973 | |
| GeneOntologyCellularComponent | actin filament | 5.54e-06 | 146 | 232 | 10 | GO:0005884 | |
| GeneOntologyCellularComponent | collagen trimer | 5.61e-05 | 88 | 232 | 7 | GO:0005581 | |
| GeneOntologyCellularComponent | adherens junction | PKP2 DLG4 PDLIM2 JCAD SHROOM3 APC SHROOM2 CDH22 HMCN1 CTNND1 | 1.35e-04 | 212 | 232 | 10 | GO:0005912 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 DBN1 PKP2 DLG4 PDLIM2 JCAD SHROOM3 WAS APC SHROOM2 CD3E CDH22 HMCN1 CTNND1 ARHGEF2 PATJ TJP3 | 3.44e-04 | 591 | 232 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | catenin complex | 4.16e-04 | 32 | 232 | 4 | GO:0016342 | |
| Domain | PDZ | 4.68e-05 | 141 | 221 | 9 | PF00595 | |
| Domain | Collagen | 6.67e-05 | 85 | 221 | 7 | IPR008160 | |
| Domain | Collagen | 6.67e-05 | 85 | 221 | 7 | PF01391 | |
| Domain | PDZ | 6.83e-05 | 148 | 221 | 9 | SM00228 | |
| Domain | - | 7.58e-05 | 150 | 221 | 9 | 2.30.42.10 | |
| Domain | PDZ | 7.98e-05 | 151 | 221 | 9 | PS50106 | |
| Domain | PDZ | 8.39e-05 | 152 | 221 | 9 | IPR001478 | |
| Domain | SM_dom_ATX | 1.39e-04 | 2 | 221 | 2 | IPR025852 | |
| Domain | LsmAD | 1.39e-04 | 2 | 221 | 2 | PF06741 | |
| Domain | LsmAD_domain | 1.39e-04 | 2 | 221 | 2 | IPR009604 | |
| Domain | LsmAD | 1.39e-04 | 2 | 221 | 2 | SM01272 | |
| Domain | SM-ATX | 1.39e-04 | 2 | 221 | 2 | PF14438 | |
| Domain | ASD1 | 4.15e-04 | 3 | 221 | 2 | PF08688 | |
| Domain | ASD1_dom | 4.15e-04 | 3 | 221 | 2 | IPR014800 | |
| Domain | ASD1 | 4.15e-04 | 3 | 221 | 2 | PS51306 | |
| Domain | Laminin_G | 6.10e-04 | 58 | 221 | 5 | IPR001791 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 TMEM94 ANKRD9 SFI1 SRCAP TINAGL1 SBF1 SH3TC1 IFRD2 PCYT2 WDR90 FAM89A SHROOM3 B4GALNT4 ARID3A ZNF628 MTHFD1L KMT5C CHSY1 TBC1D25 MADD SBNO2 RADIL GET4 MEGF8 CTDP1 NUP188 SLC45A1 ARHGEF2 ARHGAP33 AHNAK2 PCNT TJP3 | 3.46e-12 | 1105 | 246 | 33 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L CCDC8 GAPVD1 N4BP3 SBF1 SYDE2 PKP2 JCAD SHROOM3 POTEF APC PLEKHG2 CBL SPECC1 MADD RADIL MEGF8 MEPCE CTNND1 ARHGEF2 PATJ RAB21 DMTN AHNAK2 | 1.40e-08 | 861 | 246 | 24 | 36931259 |
| Pubmed | DDN EWSR1 DBN1 SYNGAP1 SBF1 PLPPR4 ATXN2 GPR158 DLG4 SHANK1 VGF SHROOM3 APC PPFIA3 BCL11B YLPM1 DCHS1 APPL1 ALYREF CTNND1 ARHGEF2 CUX1 PCNT | 4.40e-07 | 963 | 246 | 23 | 28671696 | |
| Pubmed | ATXN2L BCL9L TSPOAP1 HMGCS1 DBN1 ECI1 SYNGAP1 PLPPR4 GPR158 GLUD2 KCNQ3 DLG4 SHANK1 JCAD USP24 APC PPFIA3 SHROOM2 MADD OSBP TCF25 APPL1 CTNND1 RAB21 PCCB | 6.43e-07 | 1139 | 246 | 25 | 36417873 | |
| Pubmed | Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex. | 8.71e-07 | 46 | 246 | 6 | 35864088 | |
| Pubmed | GAPVD1 EWSR1 N4BP3 PKP2 CBL SHROOM2 RADIL CEP250 ACIN1 CTNND1 ARHGEF2 | 2.33e-06 | 255 | 246 | 11 | 15324660 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSPOAP1 DDN APOBR SYNGAP1 TMEM132C ZNF469 ATXN2 WDR90 JCAD SHROOM3 YLPM1 IGSF9B PATJ PCNT | 2.75e-06 | 430 | 246 | 14 | 35044719 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ATXN2L BTBD6 EWSR1 N4BP3 CXXC1 AXIN2 SYNGAP1 PCYT2 DLG4 SHANK1 ARX SPECC1 MEGF8 CCBE1 TCF25 PCCB | 2.88e-06 | 560 | 246 | 16 | 21653829 |
| Pubmed | ATXN2L GAPVD1 PPAN CCDC9B EWSR1 HMGCS1 AXIN2 ZNF608 SUN2 PKP2 SYNCRIP NT5E APC SPECC1 RNF6 MEPCE ACIN1 ALYREF CTNND1 ARHGEF2 PATJ DDX21 BBC3 CUX1 TJP3 | 3.23e-06 | 1247 | 246 | 25 | 27684187 | |
| Pubmed | COL6A5 TINAGL1 DMBT1 COL4A6 COL16A1 COL27A1 EMILIN1 HMCN1 LOXL1 | 3.25e-06 | 167 | 246 | 9 | 22159717 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L CCDC8 GAPVD1 PPAN DHX38 SRCAP SBF1 PKP2 APC YLPM1 ZBTB10 NUP188 CTNND1 ARHGEF2 | 3.58e-06 | 440 | 246 | 14 | 34244565 |
| Pubmed | ATXN2L EWSR1 DBN1 ATXN2 SYNCRIP JCAD MEPCE ACIN1 CTNND1 PATJ DDX21 | 4.63e-06 | 274 | 246 | 11 | 34244482 | |
| Pubmed | COL6A5 TINAGL1 DMBT1 COL4A6 COL16A1 COL27A1 EMILIN1 HMCN1 LOXL1 | 4.76e-06 | 175 | 246 | 9 | 28071719 | |
| Pubmed | RTEL1 ADGRV1 LRCH1 ZNF608 NRXN2 GPR158 THSD7A PPFIA3 APPL1 PCNT | 5.18e-06 | 225 | 246 | 10 | 12168954 | |
| Pubmed | GAPVD1 SFI1 ADGRV1 LRCH1 SBF1 PLPPR4 ZNF608 NRXN2 WDR90 SHROOM3 CHSY1 TUBGCP6 LRIG3 NUP188 ZNF646 | 6.46e-06 | 529 | 246 | 15 | 14621295 | |
| Pubmed | ATXN2L DBN1 SYNGAP1 SGPP1 DLG4 APC SPECC1 MADD RADIL CTNND1 ARHGEF2 DMTN | 7.82e-06 | 347 | 246 | 12 | 17114649 | |
| Pubmed | 1.20e-05 | 7 | 246 | 3 | 16059920 | ||
| Pubmed | Transforming Growth Factor-beta signaling in αβ thymocytes promotes negative selection. | 1.20e-05 | 7 | 246 | 3 | 31857584 | |
| Pubmed | 1.20e-05 | 7 | 246 | 3 | 15276201 | ||
| Pubmed | Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. | 1.20e-05 | 7 | 246 | 3 | 28453519 | |
| Pubmed | 1.62e-05 | 22 | 246 | 4 | 23658188 | ||
| Pubmed | DCHS2 STAG1 EWSR1 CUEDC1 SYNGAP1 SATB1 DLG4 RAB5B SHANK1 JCAD APC AIRE CLIC6 PDCD7 SHROOM2 SPECC1 MADD BEX3 GMCL1 YLPM1 APPL1 PCCB CUX1 PCNT | 1.65e-05 | 1285 | 246 | 24 | 35914814 | |
| Pubmed | CENPB SRCAP ZNF469 ZNF608 SH3TC1 SUN2 PKP2 DLG4 PDLIM2 CCNL2 FAT3 BEND3 PPFIA3 TUBGCP6 LRIG3 BCL11B MEPCE ZBTB10 TCF25 NUP188 ARHGAP33 ZNF646 | 1.67e-05 | 1116 | 246 | 22 | 31753913 | |
| Pubmed | 1.91e-05 | 8 | 246 | 3 | 12475935 | ||
| Pubmed | BCL9L GAPVD1 DBN1 LRCH1 PKP2 JCAD SHROOM3 APC CBL RADIL ARHGEF2 PATJ DMTN | 2.02e-05 | 446 | 246 | 13 | 24255178 | |
| Pubmed | TMEM94 SYNGAP1 ZNF608 SUN2 FDX1 CCNL2 COL4A6 DDR1 B4GALNT4 POLR3GL FAT3 USP24 SPECC1 EMILIN1 TUBGCP6 RADIL DMKN FER1L4 NUP188 CTNND1 ARHGEF2 TOR1AIP1 CFAP46 | 2.02e-05 | 1215 | 246 | 23 | 15146197 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | ATXN2L EWSR1 FBXW8 SYNCRIP ZNF628 COL27A1 CHSY1 SPECC1 ALYREF DDX21 CUX1 | 2.04e-05 | 321 | 246 | 11 | 32098917 |
| Pubmed | 2.69e-05 | 167 | 246 | 8 | 25659891 | ||
| Pubmed | 2.85e-05 | 9 | 246 | 3 | 16364570 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EWSR1 DBN1 SRCAP LRCH1 CXXC1 SYNGAP1 MOGS SBF1 NRXN2 SUN2 SYNCRIP APC PDCD7 CCDC61 YLPM1 KCTD3 ACIN1 ARHGEF2 DDX21 CBX8 ARHGAP33 | 3.28e-05 | 1082 | 246 | 21 | 38697112 |
| Pubmed | PPAN TCERG1L STAG1 DBN1 SRCAP CXXC1 POTEE ZNF608 GLUD2 FBXO15 SYNCRIP KRT7 CCDC185 POTEF BEND3 MINDY2 YLPM1 ACIN1 POTEI ARHGEF2 RAB21 DDX21 CUX1 CFAP46 PCNT | 3.73e-05 | 1442 | 246 | 25 | 35575683 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATXN2L STAG1 TMEM94 ATXN2 GPR158 SYNCRIP THSD7A USP24 APC MADD TUBGCP6 IGSF9B DDX21 | 3.86e-05 | 475 | 246 | 13 | 31040226 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATXN2L IRF2BP2 DBN1 PKP2 SYNCRIP SHROOM3 PPFIA3 SPECC1 KCTD3 TCF25 ACIN1 DDX21 CUX1 | 4.03e-05 | 477 | 246 | 13 | 31300519 |
| Pubmed | 4.04e-05 | 10 | 246 | 3 | 25088364 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | HMGCS1 N4BP3 CXXC1 SYNGAP1 SH3TC1 SUN2 DLG4 PDLIM2 DNASE2 SYNCRIP MIR1915HG CCDC61 BEX3 MEGF8 DMKN CGREF1 CEP250 MEPCE ACIN1 SRRM3 | 4.46e-05 | 1021 | 246 | 20 | 26760575 |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 32113662 | ||
| Pubmed | Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism. | 4.98e-05 | 2 | 246 | 2 | 24352660 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 4.98e-05 | 2 | 246 | 2 | 19669888 | |
| Pubmed | Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. | 4.98e-05 | 2 | 246 | 2 | 21982234 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 19491259 | ||
| Pubmed | Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis. | 4.98e-05 | 2 | 246 | 2 | 23447577 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 11809809 | ||
| Pubmed | Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. | 4.98e-05 | 2 | 246 | 2 | 8896555 | |
| Pubmed | Human capping enzyme promotes formation of transcriptional R loops in vitro. | 4.98e-05 | 2 | 246 | 2 | 17978174 | |
| Pubmed | c-Cbl negatively regulates platelet activation by glycoprotein VI. | 4.98e-05 | 2 | 246 | 2 | 14629478 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 26342115 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 11578861 | ||
| Pubmed | Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. | 4.98e-05 | 2 | 246 | 2 | 27992401 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 18328678 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 12193717 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 19570783 | ||
| Pubmed | FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. | 4.98e-05 | 2 | 246 | 2 | 21743493 | |
| Pubmed | p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia. | 4.98e-05 | 2 | 246 | 2 | 29130932 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 15673435 | ||
| Pubmed | Repurposing of the enhancer-promoter communication underlies the compensation of Mesp2 by Mesp1. | 4.98e-05 | 2 | 246 | 2 | 35025872 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 18272690 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 11259252 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 27300007 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 17360567 | ||
| Pubmed | Genetic and functional analysis of SHROOM1-4 in a Chinese neural tube defect cohort. | 4.98e-05 | 2 | 246 | 2 | 29423651 | |
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 26088191 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 10698202 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 31457080 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 31457081 | ||
| Pubmed | 4.98e-05 | 2 | 246 | 2 | 8167223 | ||
| Pubmed | Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation. | 4.98e-05 | 2 | 246 | 2 | 10373541 | |
| Pubmed | Aire and Foxp3 expression in a particular microenvironment for T cell differentiation. | 4.98e-05 | 2 | 246 | 2 | 19077444 | |
| Pubmed | Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice. | 4.98e-05 | 2 | 246 | 2 | 27009049 | |
| Pubmed | Ndfip1 is required for the development of pyramidal neuron dendrites and spines in the neocortex. | 5.53e-05 | 11 | 246 | 3 | 23897647 | |
| Pubmed | Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. | 5.53e-05 | 11 | 246 | 3 | 31794381 | |
| Pubmed | 5.53e-05 | 11 | 246 | 3 | 9647694 | ||
| Pubmed | 5.53e-05 | 11 | 246 | 3 | 25232112 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 5.79e-05 | 30 | 246 | 4 | 15782174 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | ATXN2L CCDC8 PPAN POTEE ATXN2 IFRD2 PKP2 ZNF628 YLPM1 MEPCE TCF25 | 6.36e-05 | 364 | 246 | 11 | 24778252 |
| Pubmed | ADGRV1 LRCH1 SBF1 DLG4 DDR1 MTHFD1L APC PPFIA3 SPECC1 CEP250 KCTD3 CTNND1 | 6.37e-05 | 430 | 246 | 12 | 32581705 | |
| Pubmed | ATXN2L GAPVD1 DHX38 EWSR1 SBF1 SYNCRIP MTHFD1L USP24 BEND3 YLPM1 ACIN1 ALYREF NUP188 DDX21 PCNT | 7.29e-05 | 653 | 246 | 15 | 22586326 | |
| Pubmed | 7.34e-05 | 12 | 246 | 3 | 27300315 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 7.92e-05 | 62 | 246 | 5 | 28344315 | |
| Pubmed | 8.52e-05 | 101 | 246 | 6 | 26949739 | ||
| Pubmed | 9.00e-05 | 102 | 246 | 6 | 9734811 | ||
| Pubmed | Cortical and Clonal Contribution of Tbr2 Expressing Progenitors in the Developing Mouse Brain. | 9.49e-05 | 13 | 246 | 3 | 24927931 | |
| Pubmed | Cis-regulatory control of corticospinal system development and evolution. | 9.49e-05 | 13 | 246 | 3 | 22678282 | |
| Pubmed | 9.49e-05 | 13 | 246 | 3 | 31841517 | ||
| Pubmed | 9.49e-05 | 13 | 246 | 3 | 35289744 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ATXN2L PPAN CCDC9B DHX38 EWSR1 DBN1 LRCH1 MOGS ATXN2 SUN2 PKP2 SYNCRIP SPECC1 MEPCE ACIN1 ALYREF CTNND1 ARHGEF2 PATJ DDX21 CBX8 DMTN | 9.69e-05 | 1257 | 246 | 22 | 36526897 |
| Pubmed | 1.08e-04 | 35 | 246 | 4 | 28808228 | ||
| Pubmed | 1.10e-04 | 152 | 246 | 7 | 34299191 | ||
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 1.34e-04 | 37 | 246 | 4 | 20937701 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCDC8 GAPVD1 PPAN EWSR1 SRCAP FBXW8 RAB5B SYNCRIP SPECC1 YLPM1 ACIN1 ALYREF NUP188 CTNND1 ARHGEF2 RAB21 DDX21 TOR1AIP1 PCNT | 1.40e-04 | 1024 | 246 | 19 | 24711643 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L IRF2BP2 GAPVD1 PPAN DBN1 FBXO4 USP24 SMTN TUBGCP6 OSBP YLPM1 CTDP1 ACIN1 APPL1 ARHGEF2 DDX21 | 1.42e-04 | 774 | 246 | 16 | 15302935 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 STAG1 CENPB FBXW8 SATB1 SH3TC1 FOXP3 ARID3A CHSY1 BEND3 DMKN ZBTB10 ALYREF CTNND1 ARHGEF2 DDX21 CUX1 | 1.44e-04 | 857 | 246 | 17 | 25609649 |
| Pubmed | Ataxin-2-like is a regulator of stress granules and processing bodies. | 1.49e-04 | 3 | 246 | 2 | 23209657 | |
| Pubmed | 1.49e-04 | 3 | 246 | 2 | 26073433 | ||
| Pubmed | 1.49e-04 | 3 | 246 | 2 | 33766913 | ||
| Pubmed | 1.49e-04 | 3 | 246 | 2 | 27612426 | ||
| Pubmed | Genetic reevaluation of the role of F-box proteins in cyclin D1 degradation. | 1.49e-04 | 3 | 246 | 2 | 22124152 | |
| Pubmed | 1.49e-04 | 3 | 246 | 2 | 12427827 | ||
| Pubmed | APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells. | 1.49e-04 | 3 | 246 | 2 | 33237836 | |
| Pubmed | Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development. | 1.49e-04 | 3 | 246 | 2 | 38947320 | |
| Pubmed | 1.49e-04 | 3 | 246 | 2 | 26146642 | ||
| Interaction | ZNF683 interactions | 5.52e-08 | 10 | 240 | 5 | int:ZNF683 | |
| Interaction | CELF4 interactions | 1.00e-07 | 11 | 240 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 1.70e-07 | 12 | 240 | 5 | int:BEND2 | |
| Interaction | PTTG2 interactions | 4.21e-07 | 14 | 240 | 5 | int:PTTG2 | |
| Interaction | TOP3B interactions | TRPM4 RTEL1 TMEM94 ANKRD9 SFI1 SRCAP AXIN2 TINAGL1 MOGS SBF1 SH3TC1 ATXN2 IFRD2 PKP2 PCYT2 WDR90 SYNCRIP FAM89A SHROOM3 B4GALNT4 ARID3A ZNF628 MTHFD1L KMT5C CHSY1 TBC1D25 MADD SBNO2 RADIL GET4 MEGF8 CTDP1 ACIN1 NUP188 SLC45A1 ARHGEF2 ARHGAP33 AHNAK2 PCNT TJP3 | 7.35e-07 | 1470 | 240 | 40 | int:TOP3B |
| Interaction | MBNL3 interactions | 9.02e-07 | 16 | 240 | 5 | int:MBNL3 | |
| Interaction | OXER1 interactions | 2.01e-06 | 50 | 240 | 7 | int:OXER1 | |
| Interaction | ZNF385C interactions | 2.27e-06 | 33 | 240 | 6 | int:ZNF385C | |
| Interaction | NCK2 interactions | GGN CUEDC1 SYNGAP1 PRR20C PRR20D PRR20B PRR20E DLG4 DDR1 WAS PRR20A CBL CD3E YLPM1 | 3.35e-06 | 262 | 240 | 14 | int:NCK2 |
| Interaction | PRR34 interactions | 4.00e-06 | 21 | 240 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 4.00e-06 | 21 | 240 | 5 | int:TPRX1 | |
| Interaction | PRR35 interactions | 6.58e-06 | 83 | 240 | 8 | int:PRR35 | |
| Interaction | POTED interactions | 6.61e-06 | 4 | 240 | 3 | int:POTED | |
| Interaction | PRR20B interactions | 1.20e-05 | 90 | 240 | 8 | int:PRR20B | |
| Interaction | PRR20C interactions | 1.20e-05 | 90 | 240 | 8 | int:PRR20C | |
| Interaction | PRR20D interactions | 1.20e-05 | 90 | 240 | 8 | int:PRR20D | |
| Interaction | C3orf36 interactions | 1.23e-05 | 26 | 240 | 5 | int:C3orf36 | |
| Interaction | POTEC interactions | 1.29e-05 | 13 | 240 | 4 | int:POTEC | |
| Interaction | RBPMS interactions | LINC00588 EWSR1 SFI1 TINAGL1 PRR20C PRR20D PRR20B ATXN2 PRR20E PKP2 WDR90 FOXP3 POLR3GL PRR20A PRR35 | 1.51e-05 | 340 | 240 | 15 | int:RBPMS |
| Interaction | YWHAE interactions | ATXN2L CCDC8 GAPVD1 COL6A5 EWSR1 DBN1 N4BP3 LRCH1 SYNGAP1 FBXO4 SBF1 SYDE2 PKP2 DLG4 JCAD SHROOM3 POTEF APC CBL SHROOM2 SPECC1 BEX3 RADIL CEP250 MEPCE TCF25 APPL1 CTNND1 ARHGEF2 DDX21 ARHGAP33 DMTN GPRIN2 | 1.60e-05 | 1256 | 240 | 33 | int:YWHAE |
| Interaction | YWHAH interactions | ATXN2L CCDC8 GAPVD1 DHX38 N4BP3 SYNGAP1 SBF1 SYDE2 PKP2 PCYT2 JCAD SHROOM3 POTEF APC TBC1D25 PLEKHG2 CBL SPECC1 MADD RADIL MEGF8 MEPCE APPL1 CTNND1 ARHGEF2 PATJ RAB21 DMTN AHNAK2 PCNT | 2.08e-05 | 1102 | 240 | 30 | int:YWHAH |
| Interaction | PRR20E interactions | 2.81e-05 | 101 | 240 | 8 | int:PRR20E | |
| Interaction | ESRP1 interactions | 3.68e-05 | 77 | 240 | 7 | int:ESRP1 | |
| Interaction | RIPPLY1 interactions | 4.77e-05 | 55 | 240 | 6 | int:RIPPLY1 | |
| Interaction | PRR20A interactions | 4.86e-05 | 109 | 240 | 8 | int:PRR20A | |
| Interaction | TLX3 interactions | BCL9L PPAN DBN1 SYNGAP1 PRR20C PRR20D PRR20B SATB1 ZNF608 PRR20E ARID3A PRR20A CUX1 | 4.96e-05 | 291 | 240 | 13 | int:TLX3 |
| Interaction | POTEB3 interactions | 5.57e-05 | 35 | 240 | 5 | int:POTEB3 | |
| Interaction | ZBTB32 interactions | 6.46e-05 | 58 | 240 | 6 | int:ZBTB32 | |
| Interaction | KCNA6 interactions | 6.61e-05 | 19 | 240 | 4 | int:KCNA6 | |
| Interaction | HLX interactions | 7.34e-05 | 37 | 240 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 7.34e-05 | 37 | 240 | 5 | int:ZCCHC14 | |
| Interaction | CEP135 interactions | SFI1 GLUD2 PKP2 WDR90 JCAD SHROOM3 APC CCDC61 CEP250 CTNND1 TOR1AIP1 PCNT | 1.09e-04 | 272 | 240 | 12 | int:CEP135 |
| Interaction | TBX6 interactions | 1.21e-04 | 41 | 240 | 5 | int:TBX6 | |
| Interaction | RBM23 interactions | 1.32e-04 | 94 | 240 | 7 | int:RBM23 | |
| Interaction | FAM222B interactions | 1.36e-04 | 42 | 240 | 5 | int:FAM222B | |
| Interaction | FAM81A interactions | 1.45e-04 | 23 | 240 | 4 | int:FAM81A | |
| Interaction | SAMD11 interactions | 1.53e-04 | 43 | 240 | 5 | int:SAMD11 | |
| Interaction | BICRAL interactions | 1.53e-04 | 43 | 240 | 5 | int:BICRAL | |
| Interaction | C2CD4B interactions | 1.71e-04 | 44 | 240 | 5 | int:C2CD4B | |
| Interaction | TBX3 interactions | 1.72e-04 | 69 | 240 | 6 | int:TBX3 | |
| Interaction | KRTAP19-5 interactions | 1.83e-04 | 99 | 240 | 7 | int:KRTAP19-5 | |
| Interaction | YWHAG interactions | ATXN2L CCDC8 GAPVD1 EWSR1 N4BP3 SYNGAP1 SBF1 SYDE2 PKP2 DLG4 JCAD SHROOM3 POTEF USP24 APC PLEKHG2 CBL SHROOM2 SPECC1 RADIL CEP250 MEPCE TCF25 ACIN1 APPL1 CTNND1 ARHGEF2 PATJ DMTN AHNAK2 | 1.96e-04 | 1248 | 240 | 30 | int:YWHAG |
| Interaction | SP4 interactions | 2.11e-04 | 46 | 240 | 5 | int:SP4 | |
| Interaction | KRTAP19-1 interactions | 2.34e-04 | 47 | 240 | 5 | int:KRTAP19-1 | |
| Interaction | RHOXF2 interactions | 2.48e-04 | 104 | 240 | 7 | int:RHOXF2 | |
| Interaction | VEZF1 interactions | 2.63e-04 | 105 | 240 | 7 | int:VEZF1 | |
| Interaction | ACTG2 interactions | 2.86e-04 | 49 | 240 | 5 | int:ACTG2 | |
| Cytoband | 13q21.1 | 5.27e-09 | 13 | 246 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | GP6 TRPM4 CCDC8 GGN CLPTM1 VSIG10L SHANK1 ZNF628 KMT5C PLEKHG2 PPFIA3 CCDC61 MEGF8 DMKN BBC3 ARHGAP33 SBK3 | 2.70e-04 | 1192 | 246 | 17 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 4.36e-04 | 117 | 246 | 5 | chr13q21 | |
| Cytoband | 16p11 | 5.90e-04 | 7 | 246 | 2 | 16p11 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.95e-08 | 13 | 153 | 5 | 685 | |
| GeneFamily | PDZ domain containing | 5.89e-06 | 152 | 153 | 9 | 1220 | |
| GeneFamily | Collagens | 4.21e-05 | 46 | 153 | 5 | 490 | |
| GeneFamily | Cadherin related | 3.70e-04 | 17 | 153 | 3 | 24 | |
| GeneFamily | Ankyrin repeat domain containing | 1.07e-03 | 242 | 153 | 8 | 403 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 2.46e-03 | 9 | 153 | 2 | 527 | |
| Coexpression | GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP | 1.42e-05 | 196 | 240 | 10 | M7616 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | ATXN2L PPAN SFI1 SBF1 DNASE2 WAS THSD7A CILP NT5E APC MINDY2 CGREF1 DCHS1 DCAF11 ARHGEF2 PATJ | 1.94e-05 | 506 | 240 | 16 | M253 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SOX1 TCERG1L SFI1 ADGRV1 N4BP3 C2CD4C PKDREJ GDNF CHRNA5 BMP6 SATB1 UCN PKP2 PDLIM2 TRHDE VGF SHROOM3 COL19A1 COL27A1 ARX CLIC6 CDH22 HMCN1 CCBE1 EN1 | 1.98e-05 | 1074 | 240 | 25 | M1941 |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.37e-08 | 170 | 242 | 10 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | N4BP3 TINAGL1 ZNF608 JCAD PLEKHG2 EMILIN1 OSBP CCBE1 LOXL1 PWWP3A | 7.86e-08 | 186 | 242 | 10 | 37860daeecd6d412bd3797f30496a56da667fbd1 |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | N4BP3 TINAGL1 ZNF608 JCAD PLEKHG2 EMILIN1 OSBP CCBE1 LOXL1 PWWP3A | 7.86e-08 | 186 | 242 | 10 | 60830822d3de3147816693404fd03392e04c2b8e |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | N4BP3 TINAGL1 ZNF608 JCAD PLEKHG2 EMILIN1 OSBP CCBE1 LOXL1 PWWP3A | 7.86e-08 | 186 | 242 | 10 | baebeffdd426ce767190ddefc857cc78e6a58d36 |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANKRD9 LIX1L PKDREJ KMT5C TBC1D25 BCL11B LRRN4CL MEGF8 CEP250 | 2.83e-07 | 163 | 242 | 9 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-07 | 125 | 242 | 8 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-07 | 184 | 242 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-07 | 184 | 242 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-07 | 184 | 242 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.80e-07 | 189 | 242 | 9 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.02e-06 | 190 | 242 | 9 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | IGF2-AS CILP COL27A1 CAVIN3 LRIG3 LRRN4CL DMKN IGSF9B SLC45A1 | 1.07e-06 | 191 | 242 | 9 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 191 | 242 | 9 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 1.12e-06 | 192 | 242 | 9 | fbb34a959b9bd9cb72a5195a07f4653a957e4ca8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 142 | 242 | 8 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 142 | 242 | 8 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 193 | 242 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 193 | 242 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 193 | 242 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-06 | 195 | 242 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | CCDC8 SLCO3A1 TINAGL1 ZNF469 COL4A6 COL16A1 COL27A1 CLIC6 ARHGEF2 | 1.27e-06 | 195 | 242 | 9 | 5562665dd3beb70e2358aa32611a337bef5731c1 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 199 | 242 | 9 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-06 | 200 | 242 | 9 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.57e-06 | 200 | 242 | 9 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.79e-06 | 151 | 242 | 8 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-06 | 106 | 242 | 7 | ede8407ad253080d1fa2a6e2aacf549ce220309a | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class | 2.07e-06 | 154 | 242 | 8 | b568417d88a78d8c46688847f0f5f4989bd36387 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-06 | 162 | 242 | 8 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 164 | 242 | 8 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 170 | 242 | 8 | 064786c1f1ad7665358964765910b0ad46d14685 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 170 | 242 | 8 | 6725747df336697708b94999b3ebb40f1721da16 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.51e-06 | 171 | 242 | 8 | 09b3fa120f63c411f8a0dd6bd230a9720ce83fb1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.51e-06 | 171 | 242 | 8 | 61d622153b91702ef21b0efc7b9581e592b7ccea | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 4.73e-06 | 122 | 242 | 7 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-06 | 173 | 242 | 8 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-06 | 126 | 242 | 7 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.50e-06 | 128 | 242 | 7 | 7e3f5cea91af005f08d8e9340fb8630bf1c887c3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.50e-06 | 128 | 242 | 7 | a876303c852db2af9418d1a1711d7c950805018a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.50e-06 | 128 | 242 | 7 | 388062f840fd04cb8087f27a9a78e7a192920e3e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.58e-06 | 180 | 242 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.58e-06 | 180 | 242 | 8 | 25f8e82bbc1853cb7d072484e99369c72779dd1e | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.13e-06 | 182 | 242 | 8 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 184 | 242 | 8 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 184 | 242 | 8 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 8.04e-06 | 185 | 242 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.70e-06 | 187 | 242 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.04e-06 | 188 | 242 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.40e-06 | 189 | 242 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.40e-06 | 189 | 242 | 8 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 9.40e-06 | 189 | 242 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.40e-06 | 189 | 242 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 9.77e-06 | 190 | 242 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.01e-05 | 191 | 242 | 8 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 192 | 242 | 8 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 242 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 242 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.05e-05 | 192 | 242 | 8 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 192 | 242 | 8 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 192 | 242 | 8 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 242 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 194 | 242 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 194 | 242 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | C_06|World / shred on cell type and cluster | 1.14e-05 | 194 | 242 | 8 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 194 | 242 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.18e-05 | 195 | 242 | 8 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 195 | 242 | 8 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-05 | 196 | 242 | 8 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.22e-05 | 141 | 242 | 7 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 242 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 197 | 242 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 197 | 242 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 198 | 242 | 8 | 829377071f65016d31d09175a43c28e95532b404 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 198 | 242 | 8 | 27a3c1c5ac855dff8d63f44eaa289be3f5bd621a | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 198 | 242 | 8 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-05 | 198 | 242 | 8 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 198 | 242 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 18-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 1.32e-05 | 198 | 242 | 8 | be200dc5b9d95c2d37998b29c59418f0ba68d2bb | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.37e-05 | 199 | 242 | 8 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-BMP_responsible_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-05 | 200 | 242 | 8 | 8433f4d3e26f6706bc7f06597d10b89221ce6437 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.42e-05 | 200 | 242 | 8 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-05 | 200 | 242 | 8 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 200 | 242 | 8 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.42e-05 | 200 | 242 | 8 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.42e-05 | 200 | 242 | 8 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 200 | 242 | 8 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | medial-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 200 | 242 | 8 | 0079041c3e654c1ef77c492bdb2f31ce8f4b507b | |
| ToppCell | Parenchyma_Control_(B.)|World / Sample group, Lineage and Cell type | 1.42e-05 | 200 | 242 | 8 | 220b6e5f936b3d08b031d6cabc5793213b98b8e2 | |
| ToppCell | medial-Epithelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.42e-05 | 200 | 242 | 8 | 17bb9a9016058cbb70c7bd894c12f6208ff07895 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.47e-05 | 145 | 242 | 7 | e932361734839c14ffa0c1e028dcef9c833f884f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.54e-05 | 146 | 242 | 7 | a4f2e3ea79e7154873c01739672ec6454547e6a6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-05 | 148 | 242 | 7 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 149 | 242 | 7 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 1.83e-05 | 150 | 242 | 7 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 101 | 242 | 6 | cf52c93f523c5f25bd45519a1444ce7bd1d8b577 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 1.99e-05 | 152 | 242 | 7 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 152 | 242 | 7 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.17e-05 | 154 | 242 | 7 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 154 | 242 | 7 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-05 | 155 | 242 | 7 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.88e-05 | 161 | 242 | 7 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | PRSS22 TINAGL1 VGF COL4A6 APC MEGF8 CGREF1 SMPD1 PATJ BBC3 ARHGAP33 | 6.20e-06 | 191 | 240 | 11 | 3811_DN |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | TRPM4 TMEM94 SRCAP FANCE SBF1 USP24 PPFIA3 SBNO2 SMTN RNF6 CTDP1 | 7.92e-06 | 196 | 240 | 11 | 7234_DN |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 8.31e-06 | 197 | 240 | 11 | 2558_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; HL60; HT_HG-U133A | GP6 HMGCS1 SFI1 SGPP1 APC GALNT12 MINDY2 CEP250 YLPM1 TJP3 ZNF646 | 8.72e-06 | 198 | 240 | 11 | 2397_UP |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | FANCE SBF1 SUN2 COL4A6 WAS R3HCC1 PPFIA3 SLC4A2 BCL11B ARHGEF2 CBX8 | 9.15e-06 | 199 | 240 | 11 | 7295_DN |
| Disease | obsolete aging, cognition | 7.60e-08 | 15 | 229 | 5 | EFO_0003925, GO_0007568 | |
| Disease | Colorectal Carcinoma | CCDC9B TCERG1L CSMD3 AXIN2 BMP6 SH3TC1 SHANK1 COL4A6 MTHFD1L APC GALNT12 SMTN OSBP CDH22 BCL11B DMKN DCHS1 VRTN ACIN1 CUX1 | 6.85e-07 | 702 | 229 | 20 | C0009402 |
| Disease | JT interval | 2.63e-05 | 248 | 229 | 10 | EFO_0007885 | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 6.00e-05 | 2 | 229 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | SAPHO syndrome | 1.53e-04 | 35 | 229 | 4 | EFO_1001164 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 1.64e-04 | 66 | 229 | 5 | EFO_0007708 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.93e-04 | 152 | 229 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Situs ambiguus | 1.96e-04 | 15 | 229 | 3 | C0266642 | |
| Disease | Wiskott-Aldrich syndrome (implicated_via_orthology) | 3.56e-04 | 4 | 229 | 2 | DOID:9169 (implicated_via_orthology) | |
| Disease | mosaic loss of chromosome Y measurement | 4.04e-04 | 80 | 229 | 5 | EFO_0007783 | |
| Disease | sexual dimorphism measurement | ATXN2L IGF2-AS GAPVD1 TNFSF12 ECI1 GDNF FANCE BMP6 ZNF608 CLPTM1 ALPK3 LINC02875 R3HCC1 APC CHSY1 MADD LOXL1 FER1L4 CEP250 PATJ | 4.25e-04 | 1106 | 229 | 20 | EFO_0021796 |
| Disease | parental longevity | GAPVD1 TCERG1L SFI1 CHRNA5 ATXN2 JCAD SHROOM3 BEND3 MIR1915HG CD3E YLPM1 SRRM3 | 5.22e-04 | 494 | 229 | 12 | EFO_0007796 |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 5.91e-04 | 5 | 229 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Intellectual Disability | UBA5 STAG1 TMEM94 SYNGAP1 NRXN2 PCYT2 DLG4 APC BCL11B CCBE1 ACIN1 | 7.98e-04 | 447 | 229 | 11 | C3714756 |
| Disease | Tinnitus, wellbeing measurement | 9.29e-04 | 96 | 229 | 5 | EFO_0007869, HP_0000360 | |
| Disease | QT interval | ATXN2L ANKRD9 LRCH1 ALPK3 PKP2 KCNQ3 PARP15 BEND3 LRIG3 PRR35 CUX1 SBK3 | 1.03e-03 | 534 | 229 | 12 | EFO_0004682 |
| Disease | reticulocyte measurement | GP6 ANKRD9 LRCH1 ZNF469 ATXN2 IFRD2 ARID3A POTEF BEND3 CBL SPECC1 SBNO2 BCL11B CCBE1 TCF25 SLC45A1 CTNND1 CUX1 | 1.54e-03 | 1053 | 229 | 18 | EFO_0010700 |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.63e-03 | 8 | 229 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.77e-03 | 31 | 229 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | phospholipids:total lipids ratio | 2.06e-03 | 227 | 229 | 7 | EFO_0020946 | |
| Disease | testosterone measurement | SOX1 ATXN2L IRF2BP2 DCHS2 STAG1 TNFSF12 SRCAP CSMD3 PKDREJ BMP6 FAM157A DDR1 SHROOM3 BEX3 BCL11B HMCN1 ZBTB10 PCCB BBC3 CBX8 | 2.35e-03 | 1275 | 229 | 20 | EFO_0004908 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.66e-03 | 74 | 229 | 4 | DOID:3748 (is_marker_for) | |
| Disease | cortical thickness | IRF2BP2 ADGRV1 LRCH1 BMP6 ZNF469 ATXN2 SHROOM3 FAT3 CHSY1 BEND3 GALNT12 MINDY2 SPECC1 BCL11B YLPM1 KCTD3 PCCB CBX8 | 2.80e-03 | 1113 | 229 | 18 | EFO_0004840 |
| Disease | glucose measurement | 3.03e-03 | 380 | 229 | 9 | EFO_0004468 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 3.15e-03 | 11 | 229 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 3.15e-03 | 11 | 229 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | osteosarcoma (is_marker_for) | 3.15e-03 | 11 | 229 | 2 | DOID:3347 (is_marker_for) | |
| Disease | platelet crit | STAG1 TNFSF12 RTEL1 ANKRD9 ADGRV1 APOBR BMP6 ATXN2 PDLIM2 JCAD CBL CCBE1 YLPM1 DCHS1 CUX1 CBX8 | 3.28e-03 | 952 | 229 | 16 | EFO_0007985 |
| Disease | lactate measurement | 3.43e-03 | 39 | 229 | 3 | EFO_0007745 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.76e-03 | 12 | 229 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.76e-03 | 12 | 229 | 2 | C3160718 | |
| Disease | Alzheimer disease, dementia | 3.76e-03 | 12 | 229 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | osteoarthritis, knee, body mass index | 3.96e-03 | 41 | 229 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | neuroimaging measurement | ATXN2L DCHS2 STAG1 LRCH1 C10orf143 BMP6 ZNF469 ATXN2 SHROOM3 FAT3 APC BEND3 GALNT12 MIR1915HG BCL11B CBX8 DMTN | 4.30e-03 | 1069 | 229 | 17 | EFO_0004346 |
| Disease | putamen volume change measurement | 4.42e-03 | 13 | 229 | 2 | EFO_0021495 | |
| Disease | Genetic chronic primary adrenal insufficiency | 4.42e-03 | 13 | 229 | 2 | Orphanet_101960 | |
| Disease | Vitiligo, response to rhododendrol | 4.42e-03 | 13 | 229 | 2 | EFO_0004208, EFO_0010824 | |
| Disease | gallbladder cancer (is_implicated_in) | 4.42e-03 | 13 | 229 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | ejection fraction measurement | 4.53e-03 | 43 | 229 | 3 | EFO_0005527 | |
| Disease | Glioma | 4.76e-03 | 87 | 229 | 4 | C0017638 | |
| Disease | Anxiety States, Neurotic | 4.83e-03 | 44 | 229 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 4.83e-03 | 44 | 229 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 4.83e-03 | 44 | 229 | 3 | C0003469 | |
| Disease | left ventricular structural measurement | 4.95e-03 | 88 | 229 | 4 | EFO_0008205 | |
| Disease | neuroticism measurement, cognitive function measurement | ATXN2L STAG1 DDN SYNGAP1 TRHDE THSD7A APC BCL11B YLPM1 IGSF9B CBX8 | 4.96e-03 | 566 | 229 | 11 | EFO_0007660, EFO_0008354 |
| Disease | urinary nitrogen measurement | 5.13e-03 | 14 | 229 | 2 | EFO_0005190 | |
| Disease | C-X-C motif chemokine 11 measurement | 5.13e-03 | 14 | 229 | 2 | EFO_0008057 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 5.15e-03 | 45 | 229 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 5.15e-03 | 45 | 229 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | age of onset of childhood onset asthma | 5.80e-03 | 92 | 229 | 4 | OBA_2001015 | |
| Disease | cryptic phenotype measurement | 5.82e-03 | 47 | 229 | 3 | EFO_0021487 | |
| Disease | gamma-glutamylphenylalanine measurement | 5.89e-03 | 15 | 229 | 2 | EFO_0021142 | |
| Disease | Common Variable Immunodeficiency | 5.89e-03 | 15 | 229 | 2 | C0009447 | |
| Disease | anemia (implicated_via_orthology) | 5.89e-03 | 15 | 229 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Dilated | 6.17e-03 | 48 | 229 | 3 | C0007193 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.54e-03 | 49 | 229 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | nervousness | 6.70e-03 | 16 | 229 | 2 | NCIT_C74532 | |
| Disease | serum albumin measurement | TNFSF12 ADGRV1 ATXN2 DLG4 SHROOM3 BEND3 CBL MIR1915HG MADD CCBE1 PCNT | 6.86e-03 | 592 | 229 | 11 | EFO_0004535 |
| Disease | Cardiomyopathy, Familial Idiopathic | 6.91e-03 | 50 | 229 | 3 | C1449563 | |
| Disease | Tourette syndrome | 6.91e-03 | 50 | 229 | 3 | EFO_0004895 | |
| Disease | worry measurement | 7.16e-03 | 154 | 229 | 5 | EFO_0009589 | |
| Disease | Benign neoplasm of stomach | 7.55e-03 | 17 | 229 | 2 | C0153943 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 7.55e-03 | 17 | 229 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 7.55e-03 | 17 | 229 | 2 | C0496905 | |
| Disease | plasma protease C1 inhibitor measurement | 7.55e-03 | 17 | 229 | 2 | EFO_0008261 | |
| Disease | Carcinoma in situ of stomach | 7.55e-03 | 17 | 229 | 2 | C0154060 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 7.71e-03 | 52 | 229 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 7.75e-03 | 157 | 229 | 5 | DOID:224 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGGNGSLPGSARRNH | 86 | Q9UKU6 | |
| GNSDTEGGQPGRKRR | 836 | Q9UKV3 | |
| PGGERESTQRLGGQR | 21 | Q8N715 | |
| EVSPAQRDGGALGRG | 86 | P01160 | |
| RGNPSGGGNVQHRAG | 506 | Q01844 | |
| QGSCAQGGRVAPGQR | 426 | Q9Y5B0 | |
| GNRSLAGQSGQGKPR | 881 | P04920 | |
| QQRNRLGSGGSGDGP | 366 | Q9Y6R9 | |
| DQGNPGRTTIGAAGL | 411 | Q14031 | |
| RLIRAAGPSAAGGGN | 126 | Q9Y4M8 | |
| ERQGGLARRQGGLAG | 41 | Q969G5 | |
| NGTRNGDGREPGDTV | 1536 | Q7Z407 | |
| GGEGHQPAGNRRGQA | 26 | Q00994 | |
| GLLRNRGPGGSAEAS | 36 | P10109 | |
| GREQGQDGTAGAPGL | 16 | P17405 | |
| PGRDGQQGQTGLRGT | 846 | Q07092 | |
| RGATGERGLAGLPGQ | 1316 | Q07092 | |
| GSGGGSQPRAERSQL | 856 | P39880 | |
| NSNAGAAVGRKAGPR | 71 | Q96KE9 | |
| ALAGGAAPGVARAQR | 131 | Q96PG8 | |
| NSRDGEAGRAGAAPV | 781 | Q92974 | |
| NLGGNLGDPRARAVS | 321 | Q08345 | |
| GPGLNGPSSRNRRDG | 31 | Q8N2C3 | |
| TAGLPQRQIDGIGSG | 206 | Q9UKT5 | |
| PGILRIGAGINGNDR | 1461 | Q8WXG9 | |
| ARQGEGQSRLVPGRG | 16 | Q96L96 | |
| GGEPRRGFSDLEGQA | 2551 | Q8IYW2 | |
| SFDLGRPGGAGQNIS | 826 | Q5M775 | |
| PRLGLGDGSGVLNNR | 166 | Q86Y34 | |
| GGAGALQLPREEGDR | 601 | Q9Y2T1 | |
| GRVVSRPQRLGQGSG | 6 | Q9BSW2 | |
| LVENGPETGGAGRLA | 311 | Q9BXJ7 | |
| GPRGEAGGQAEAREN | 271 | Q99674 | |
| GPAEGSGEAARVNGR | 421 | Q96NY7 | |
| QALGPAASGAQGRAE | 571 | O94850 | |
| GGREGLLGQRRPQDG | 41 | Q6UB35 | |
| GALAQVGSPGAGRRR | 171 | Q8TF44 | |
| PVAAAGSGLRRGAEG | 61 | Q8WWM7 | |
| GSGLRRGAEGILAPQ | 66 | Q8WWM7 | |
| AQGAAPGGGEARLGQ | 261 | O43918 | |
| QGARAGGSARRPDTG | 21 | Q96IK5 | |
| GNARPTGGVGAVALL | 166 | Q01581 | |
| SNQGAAAVPRGARAG | 111 | Q9Y3T6 | |
| KGNGSSQPGTARRGV | 191 | Q9UL25 | |
| PQNLGGAAGRSRGVD | 186 | P61020 | |
| TGEARGQDGSGRRGP | 1581 | O95153 | |
| GQDGSGRRGPQKRGV | 1586 | O95153 | |
| NGLSGLRGAAPEGDS | 936 | Q96JH8 | |
| QGNGEQAGRGRSLGN | 96 | Q5T5X7 | |
| GEQAAGLAAVPRGGS | 66 | Q5JQC4 | |
| PQRLGAGAAARAGEG | 171 | Q5JQC4 | |
| VGPQFRGQTRGLCGN | 521 | Q6W4X9 | |
| GVTAGNGDNGLIPQR | 436 | A5A3E0 | |
| GPGGAGARLLRVQVQ | 1411 | Q96JQ0 | |
| RPAARGGAGETTGQQ | 36 | Q5T4H9 | |
| DREAGSVLPAGNRGA | 36 | Q460N3 | |
| GAVRLRPAGTAAGDG | 36 | O95278 | |
| ASRVPQAGGEGLEGA | 161 | Q8ND94 | |
| TEAGPGSGEGNRRAL | 896 | Q8WXG6 | |
| LGARGPGGTFQGRDL | 36 | Q9BZS1 | |
| RGGGPQAQSHGEARL | 86 | Q7L2J0 | |
| GLDSGSRQGLLGPRA | 271 | Q86Y97 | |
| GAQVRLSSARPGGLG | 21 | P08729 | |
| EERRPSLQGNTLGGG | 366 | Q86U10 | |
| GRGELGQPSGVAAER | 31 | Q6UXM1 | |
| QLGLGAVGASRDPQG | 16 | Q5T848 | |
| LANGLGPGGDSNRRT | 221 | O75145 | |
| GLGRGRNSNKGLPQS | 241 | Q99700 | |
| GQGQGRRPGLVSAVL | 201 | Q0VG99 | |
| GLVSPGSGDRAQRLG | 1301 | Q9P266 | |
| GGGRDEGQRRTPQGI | 71 | O43525 | |
| PGQAKAFGQGGRRTN | 466 | Q9UKG1 | |
| LRGRGARAGPGEQSL | 216 | Q9BZ68 | |
| PGAGLRDSLQGLNEG | 316 | A9Z1Z3 | |
| EGAVGGNEARLPNFG | 861 | Q14C86 | |
| PPGGERNGAQQGRLS | 341 | Q08397 | |
| GVQLRGRAQGGGALR | 291 | Q9GZN4 | |
| GRAQGGGALRAPSQG | 296 | Q9GZN4 | |
| RNQGIEGSPGGRVTR | 186 | Q6ZUT6 | |
| SARGVRGARGGAQQQ | 531 | O60506 | |
| PLTRKSNGGQDGGRQ | 316 | Q9HCN6 | |
| VGSGRGEQASGDPAL | 41 | Q8N3Y1 | |
| MIRNGRGAAGGAEQP | 1 | Q99447 | |
| ALQPRASAEASRGGG | 61 | Q8N8D1 | |
| RRPGSGTDGLRLQGA | 206 | C9JC47 | |
| RGGGGGTAAPQELNN | 21 | Q9NWM3 | |
| RRGQVRLVQGGGAAN | 51 | Q8TEB1 | |
| QRRRQLLAGTGPGGE | 66 | Q9NP08 | |
| LLAGTGPGGEARARA | 71 | Q9NP08 | |
| PNGLLLFSQGRRAGG | 526 | Q9P2S2 | |
| RPGSGTDGLRLQGAE | 211 | P0CG43 | |
| NVRGSSRGLGQVPGE | 1731 | Q7Z7M0 | |
| GSGGFNLPLNRGLER | 51 | Q9Y2L9 | |
| AQRLQPGVGTSGRGT | 6 | Q8IVB5 | |
| AAANPENSRGKGRRG | 96 | P39905 | |
| PLAVGAGGRGLQQAE | 871 | Q96RT7 | |
| AGGRGLQQAEGARPF | 876 | Q96RT7 | |
| GNGEGASTLQGEPRA | 481 | Q16643 | |
| PRNQGQTAGRARGGA | 206 | Q86UU5 | |
| GGNLPGSSGRRVTQV | 431 | Q9ULW8 | |
| GPARRALAGSGQLGL | 6 | Q9BZE1 | |
| AGGGGRVERDRGQTA | 136 | Q05925 | |
| QPVIGENGGDARQRG | 656 | P22059 | |
| GGPRGQALQGELEAA | 1781 | O95613 | |
| GLTIRNRGLGGQAGP | 276 | Q8TDS5 | |
| NRGLGGQAGPQRAMR | 281 | Q8TDS5 | |
| NGGRACGGPDSQIQR | 4791 | Q96RW7 | |
| AQAGGNQALPRLAGS | 341 | Q13724 | |
| HPRGSGEGQGQILQR | 16 | O95248 | |
| RARQVPGAGSGGGAL | 336 | Q6V1P9 | |
| ARVEQRLGQLGPAGG | 416 | P0CG20 | |
| RAGPRGDAGQRQGAE | 91 | P86480 | |
| GASAGNGDDGLIPQR | 436 | A0JP26 | |
| VGAPVIGLNDSGGAR | 151 | P05166 | |
| IGGRDQGRPFQGQVS | 251 | P58401 | |
| GVTAGNGDNGLIPQR | 436 | Q6S8J3 | |
| RAGPRGDAGQRQGAE | 91 | P86496 | |
| RAGPRGDAGQRQGAE | 91 | P86481 | |
| PAQVSAQLRAGGGGR | 996 | O14559 | |
| AQLRAGGGGRDAPEA | 1001 | O14559 | |
| LPGAALGRTERAAGG | 21 | P42126 | |
| LAGAAGGAQRGLSEP | 26 | P30532 | |
| DQAAGLCGGDGRPRQ | 206 | P07199 | |
| PDLQRRAGSGTGVGA | 116 | Q9P0U4 | |
| GGSRRRAPAPAGQQQ | 36 | Q6U949 | |
| VDGRGGNNGGVSRVS | 201 | P17658 | |
| APQEGGAQRTAGAGL | 251 | Q0VDD7 | |
| ELSRNRENGGGGVPG | 561 | Q9C0K0 | |
| GQGALDPNGTRVRHG | 296 | Q9HC52 | |
| PALRGSGEAAQRGLQ | 36 | O00115 | |
| VPGFGVADALGNRVG | 86 | Q6E0U4 | |
| ERGDQGIPGDRGSQG | 951 | Q14993 | |
| LQTLRGPSRGGGAAR | 16 | Q8NCQ5 | |
| QARGLLPGGTQVLDG | 311 | Q96S94 | |
| GDLGPVGQTGQRGRQ | 1636 | A8TX70 | |
| PSRGGAARGQLGRSL | 6 | Q6UXH8 | |
| GAQSREPNGSGRMDG | 226 | Q9BV73 | |
| DGAAGQGPGRGLTAR | 191 | Q86X59 | |
| GGNPRGRFALGLVQS | 2966 | Q8TDW7 | |
| GIPFRNLRGSGDGRN | 4206 | Q8TDW7 | |
| GEAAAPGNGQRSLVG | 381 | Q86UU0 | |
| GQLLGDGGSPGRTEQ | 41 | P22004 | |
| VLRAQRGAGAGAAEP | 36 | Q8IXK2 | |
| RQLGRDAGATPSAAG | 201 | Q96BM1 | |
| PVTRGAGAGGRQRGQ | 161 | P07766 | |
| AGAGGRQRGQNKERP | 166 | P07766 | |
| GQQGVAGERGHLGSR | 1096 | Q8IZC6 | |
| AGAPGRRGVQGLQGL | 1411 | Q8IZC6 | |
| PLGTQEARRASGGRG | 231 | P0C7T7 | |
| PGGAAAQDGRLRVND | 101 | P78352 | |
| KGGQRRGGGARSSAQ | 76 | Q12894 | |
| PGGGRLLQGAAAAAA | 91 | Q96QS3 | |
| PRGSGSLLRQGAEGA | 436 | P22681 | |
| APGARQDGALGAGRV | 46 | Q9UJ99 | |
| GGQAGLGRRLGALNS | 781 | Q9Y6C2 | |
| QALQAGPEGARRGLG | 31 | Q9HB96 | |
| SRGPRGQRSGGGNKS | 751 | Q9NR30 | |
| TSGQGGQAPAGLERD | 161 | O60269 | |
| QREGAAGNQRAGAPA | 311 | Q9H0W5 | |
| GNARFGQGSGPIVLD | 1431 | Q9UGM3 | |
| GNARFGQGSGPIVLD | 1691 | Q9UGM3 | |
| PGLQNGEGQRGRMDR | 316 | Q08495 | |
| GEGQRGRMDRGNSLP | 321 | Q08495 | |
| ARGNYDAAQRGPGGV | 56 | P35542 | |
| QGNREGPGVLGSAVS | 311 | P0C264 | |
| AAGGGGPETSRRRNV | 496 | Q9Y2W3 | |
| QRRLGPREVGGQGAG | 466 | Q7Z5L9 | |
| EGEARGNGTQPVLSG | 156 | Q9Y597 | |
| QTLGRDFRKNGNGGP | 176 | O60716 | |
| SAALLGRGRGQPAAA | 26 | P49448 | |
| RTPQGNALLVGVGGS | 2946 | Q8TE73 | |
| GASAGNGDDGLIPQR | 436 | B2RU33 | |
| GASAGNGDDGLIPQR | 436 | Q86YR6 | |
| GNGLGAAAARRSLPD | 51 | Q8NBR6 | |
| VLPAGGGAQDESGSR | 191 | Q2TAK8 | |
| RQRPAGTVGAGGEDA | 1186 | Q9NZ71 | |
| DGERGGGGRPRQQVS | 46 | Q5VT97 | |
| EGPLLNRIAAGAGDG | 956 | A8K8P3 | |
| GGRGRGRGQLTFNVE | 6 | Q9BT43 | |
| PQRNGGSGQRSGAHG | 311 | A6NNA2 | |
| GAQQGRGRRELAPGL | 21 | Q9GZM7 | |
| ARQRGLGGRGLQEAA | 341 | O15240 | |
| ASQGPGGGGRLLRQA | 491 | Q3MII6 | |
| GGGRSGELQGDEAQR | 11 | Q9UIG8 | |
| RPGAGRAAAQGEAEA | 41 | Q9UPZ6 | |
| GAQEGCGPGRQARAI | 856 | Q9UPZ6 | |
| NSRADGGRLAGEGQL | 871 | Q8N3T6 | |
| ESARNGGRNRGGVQR | 11 | Q7L5D6 | |
| LQPSGRLDRRGGAGT | 31 | Q6ZQX7 | |
| AAPGAAGNGAVRGLR | 6 | Q96GI7 | |
| AGNGAVRGLRVDGLP | 11 | Q96GI7 | |
| QAAVSGAPGGLLRGA | 31 | Q9NTG1 | |
| RAGPRGDAGQRQGAE | 91 | P86479 | |
| RAGPRGDAGQRQGAE | 91 | P86478 | |
| DGGGAPNGVRNGLAA | 81 | Q9BX95 | |
| RNGIGGAAGIPRANA | 236 | Q9Y252 | |
| RQGGRQAQAAGDPQG | 246 | Q13796 | |
| QLSGGASDSGRGPQR | 866 | Q8TF72 | |
| GERRRGDLLSGANGG | 1181 | Q8TF72 | |
| GAAGGGPERQSVIQF | 1341 | Q9Y2G9 | |
| GPRDAGNGPQALRQA | 226 | Q8TE82 | |
| SRALGPTGQAGSRGL | 171 | Q9BR26 | |
| GVTAGNGDDGLIPQR | 436 | P0CG38 | |
| TRTQAEGQGQGRGLG | 176 | Q9BRJ9 | |
| VGAAAVGQRLESPGG | 161 | O00570 | |
| ADVEIRGQGTGRPGQ | 2726 | Q6ZRS2 | |
| LGELRERAPGQGTNG | 36 | Q08648 | |
| PGSRQAGLGRAGDSA | 176 | Q96JY6 | |
| NGSPLGRGRLGSTGA | 36 | Q01826 | |
| LGGERERQPCGDGNT | 16 | O75908 | |
| GAPGSLASVRGLQGR | 46 | Q9Y566 | |
| GGGIRSPIDERNNGT | 391 | P21589 | |
| TQGGREGQARTLGPA | 596 | Q76KP1 | |
| QPGRGFQSGVGRAGV | 341 | Q8IVF2 | |
| QAFRGDGVPRVLGGQ | 181 | Q99856 | |
| PNELAAGEGVRGGAQ | 1666 | P25054 | |
| RGSQNEGAGRLRGPG | 71 | Q0VD83 | |
| DQAGPGGAPRVASRN | 81 | O96005 | |
| QRASRGGQRQGGVVA | 1156 | O75339 | |
| GGQRQGGVVASLRFP | 1161 | O75339 | |
| SQAGGARGDARGAQL | 56 | Q86X52 | |
| GQGRLSTGISQNGGR | 71 | A0A1B0GUT2 | |
| LGGGEDSTARGNRPV | 321 | Q5VWI1 | |
| RRNGVGLEPNINAGG | 151 | Q7Z2D5 | |
| TLGGRERPGAAGTQL | 76 | C9J3V5 | |
| GRPEQQRLAAGYGDG | 1491 | Q96KV7 | |
| REGRGRLAPQNGGSS | 26 | Q5JTV8 | |
| ERLELRQGAPGQGGG | 306 | Q9UH99 | |
| LQGDGPGGRLNSSSV | 846 | Q96PV0 | |
| GQPAGSRGVGLVNAS | 86 | Q12767 | |
| GGLEGRLQATGQARP | 941 | Q9UPX0 | |
| DKSQGAQARRGPRGA | 441 | Q9NQ55 | |
| VPGGLADRDGRLQTG | 276 | Q8NI35 | |
| PAGRAARGQAERAQG | 191 | O15370 | |
| ARGQAERAQGPSGEG | 196 | O15370 | |
| VRAQQRGGSGGEGAS | 201 | Q5TF21 | |
| QERSLQVPRSGDGGG | 21 | Q9GZZ9 | |
| RGVQGGPLRGSSGAQ | 301 | O43278 | |
| GPGESVERARGGQAV | 1651 | O15015 | |
| APGGGRGALLDQIRQ | 426 | P42768 | |
| LGVQPSALAGRRGDA | 66 | Q6ZSV7 | |
| PRSDGAEGQGQGQLL | 796 | Q5SRE5 | |
| TAQERLDQGGGSLGP | 76 | Q6UX34 | |
| GAGRGRANGHPQQNG | 66 | Q8WVM7 | |
| NQRSGRAGRTGPGQC | 851 | Q92620 | |
| SVAEAQGRLAGPSGG | 261 | A8MZF0 | |
| LVNRGRGQAISRGPG | 1036 | P49750 | |
| VRLPAGGGAQDARGL | 1021 | Q8IUG5 | |
| DGGVGQGALLGAAQR | 346 | Q6ZMY9 | |
| ALGSPRAAQGLGFRG | 76 | Q6ZRN7 | |
| EAAGAGRAQGRGRPA | 3066 | Q96JG9 | |
| GRRSPGGGSEANGLA | 161 | O95049 | |
| ENGRSVDQGGGGSPR | 1931 | Q9UPU5 | |
| NRGGANGKGRRGSLN | 461 | Q9ULD9 | |
| RPGQDGAQAGVDGTV | 116 | O43508 | |
| ISQSLARRQGPGGGA | 1286 | Q9H7P9 | |
| GGLGNNGSSRGRPET | 131 | Q96DT7 | |
| APGGGSRLRLSQDGR | 621 | Q86VR7 | |
| GGPSREGALQEGATA | 601 | Q9H8Y1 | |
| LGELRERAPGQGTNG | 36 | Q6PDA7 | |
| GQGGRITRSGVRDQP | 486 | Q99959 | |
| RRPGGAGKEGVRVNN | 46 | Q9BQ70 | |
| TDAVAPGNKGRGQRG | 86 | Q9BQ70 | |
| SPGARNQGGGARALL | 41 | P55089 | |
| LQEARGRPGEGRGNT | 631 | P53814 | |
| PGSGGARQGEARDRI | 321 | Q8TD43 | |
| GGRGGGAQAAARVNR | 36 | Q86V81 | |
| GAQAAARVNRGGGPI | 41 | Q86V81 | |
| FRQALRLPGEGGNGT | 111 | Q2TAM9 | |
| RARQGPRAVGKAGQG | 756 | Q5EBL2 | |
| AALAGSRGSRQPDGL | 31 | O15049 |